UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 83 filers reported holding UROGEN PHARMA LTD in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $809,862 | +70.4% | 57,806 | +25.9% | 0.00% | – |
| Q2 2023 | $475,272 | -19.2% | 45,920 | -32.0% | 0.00% | – |
| Q1 2022 | $588,000 | +2.6% | 67,486 | +11.9% | 0.00% | – |
| Q4 2021 | $573,000 | -44.5% | 60,289 | -1.7% | 0.00% | – |
| Q3 2021 | $1,032,000 | +20.6% | 61,334 | +9.4% | 0.00% | – |
| Q2 2021 | $856,000 | -17.1% | 56,057 | +5.7% | 0.00% | – |
| Q1 2021 | $1,033,000 | +10.5% | 53,031 | +2.2% | 0.00% | – |
| Q4 2020 | $935,000 | -9.8% | 51,886 | -3.5% | 0.00% | – |
| Q3 2020 | $1,037,000 | -28.2% | 53,753 | -2.8% | 0.00% | – |
| Q2 2020 | $1,444,000 | +67.9% | 55,313 | +14.8% | 0.00% | – |
| Q1 2020 | $860,000 | -46.6% | 48,196 | -0.1% | 0.00% | – |
| Q4 2019 | $1,610,000 | +46.1% | 48,235 | +4.3% | 0.00% | – |
| Q3 2019 | $1,102,000 | -31.0% | 46,243 | +4.0% | 0.00% | – |
| Q2 2019 | $1,598,000 | +279.6% | 44,448 | +398.1% | 0.00% | – |
| Q3 2018 | $421,000 | – | 8,923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,252,285 | $24,156,000 | 7.72% |
| Horton Capital Management, LLC | 375,428 | $7,242,000 | 6.96% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $56,996,000 | 1.27% |
| Phoenix Holdings Ltd. | 901,979 | $16,405,000 | 0.69% |
| SHIKIAR ASSET MANAGEMENT INC | 44,550 | $859,000 | 0.33% |
| Coastal Bridge Advisors, LLC | 37,000 | $714,000 | 0.22% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $14,242,000 | 0.20% |
| Clal Insurance Enterprises Holdings Ltd | 529,388 | $10,212,000 | 0.17% |
| Vivaldi Capital Management LP | 10,000 | $233,000 | 0.05% |
| MEITAV INVESTMENT HOUSE LTD | 48,407 | $934,000 | 0.05% |